JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH & DEVELOPMENT, LLC
Limited Liability Company · WILMINGTON, United States · LEI 5493004FCLKVWTRI3S10
LEI lapsed
Summary
JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH & DEVELOPMENT, LLC is registered in the United States. Its legal form is Limited Liability Company. According to GLEIF, its ultimate parent is Johnson & Johnson (United States), which is also its direct parent. That group has 209 subsidiaries with LEIs in 47 countries, 55 of them in the United States. The LEI was first issued on 3 Apr 2013 and the record was last updated on 19 Sep 2024. It has lapsed: renewal was due by 19 Sep 2024. AssetCensus found 2 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 19 Sep 2024 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent relationship record was not renewed; it was last updated on 19 Sep 2024.
Company details
| Legal form | Limited Liability Company |
|---|---|
| Register | · Register website |
| Registration number | 4702365 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER, 19801 WILMINGTON, United States |
| Headquarters address | 1400 McKean Road, 19477 Spring House, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 24 Jun 2009 |
| LEI | 5493004FCLKVWTRI3S10 |
| LEI status | lapsed |
| LEI first issued | 3 Apr 2013 |
| LEI record last updated | 19 Sep 2024 |
| Next LEI renewal | 19 Sep 2024 |
| Corroboration of the LEI record | fully corroborated |
Group membership
JANSSEN ALZHEIMER IMMUNOTHERAPY RESEARCH & DEVELOPMENT, LLC this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Johnson & Johnson | Johnson & Johnson |
| Accounting period | 1 Jan 2024 to 31 Dec 2024 | 1 Jan 2024 to 31 Dec 2024 |
| Evidence | supporting documents | supporting documents |
| Corroboration | fully corroborated | fully corroborated |
| Relationship start | 24 Jun 2009 | 24 Jun 2009 |
| Recorded at GLEIF since | 31 May 2024 | 31 May 2024 |
| Last updated | 19 Sep 2024 | 19 Sep 2024 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (97)
- ACCLARENT, INC. United States
- ACTELION PHARMACEUTICALS US, INC. United States lapsed
- ALZA CORPORATION United States
- AMO HOLDINGS, INC. United States lapsed
- AMO SALES AND SERVICE, INC. United States
- AURIS HEALTH, INC. United States
- BIOMEDICAL ENTERPRISES, INC. United States lapsed
- BIOSENSE WEBSTER, INC. United States
- CORDIS FINANCING CORPORATION United States lapsed
- DEPUY SYNTHES PRODUCTS, INC. United States
- DEPUY SYNTHES SALES, INC. United States
- DEPUY SYNTHES, INC. United States